#United States #New York #Class Action #Securities Fraud #Dun & Bradstreet

Dun & Bradstreet Securities Fraud Class Action Lawsuit

Recently, the Rosen Law Firm has reached out to investors involved with Dun & Bradstreet Holdings, Inc. (NYSE: DNB). The firm is advocating for individuals and entities that sold shares of DNB common stock between May 13, 2025, and August 26, 2025, or exchanged their shares during its merger with Clearlake Capital Group, L.P. This merger was completed at a cash price of $9.15 per share.

Who Is Eligible?

The eligibility criteria for participation in this class action lawsuit include:
1. Individuals or entities that sold DNB common stock during the specified date range.
2. Those who exchanged their shares during the August 26, 2025 merger.
3. Shareholders who held shares as of May 9, 2025, and voted on the merger at a stockholder meeting.

If you meet any of these criteria, you could potentially receive compensation without incurring any out-of-pocket expenses, as the legal arrangement is based on a contingency fee structure.

Legal Representation and Process

To be a part of this important class action, you can visit Rosen Law Firm’s website or get in touch with attorney Phillip Kim, Esq., toll-free at 866-767-3653. Email queries can also be sent to [email protected] for further assistance related to the case. The deadline to act as the lead plaintiff in this lawsuit is November 10, 2026. Acting as a lead plaintiff means you will represent others who are part of the class and guide the direction of the litigation.

Importance of Qualified Legal Counsel

Rosen Law Firm emphasizes the significance of selecting a legal counsel with proven expertise in securities lawsuits. Many notices that investors receive may come from firms that are merely intermediaries and do not have the requisite experience in handling securities class actions. The Rosen Law Firm has established its reputation by successfully managing numerous investor cases, such as securing the largest securities class action settlement against a Chinese company in history. They have consistently ranked among the top firms for securities class action settlements and have successfully recovered billions for investors over the years.

Case Details

The lawsuit presents claims against Dun & Bradstreet for allegedly misleading investors through false statements and omissions regarding the merger. Particular focus is on communications relating to the merger announcement on March 23, 2025, and the definitive proxy statement released on May 13, 2025. The allegations suggest that the proxy materials misrepresented the actual value of the company and the transaction. Moreover, serious concerns are raised about the lack of disclosure regarding Executive Chairman Foley's vested interests in a swift sale.

Misleading Information in the Proxy Statement

The complaint details several instances of misleading information, including:

• - Misrepresentations regarding the strategy leading to the merger, suggesting it was a typical constructive approach while circumventing significant conflicts of interest.
• - The omission of superior alternatives to selling the entire company, as well as incorrect assertions regarding the Board of Directors’ approval of reduced financial projections.

Conclusion

This class action lawsuit represents a critical opportunity for investors affected by the alleged fraud at Dun & Bradstreet. Participation in such legal actions is essential not only for potential financial recovery but also for holding corporations accountable for transparency with their shareholders. As developments unfold, investors are advised to stay informed and consider joining the Rosen Law Firm's legal efforts to seek justice and compensation.

For those seeking more updates, follow the Rosen Law Firm on their LinkedIn, Twitter, and Facebook pages.